Migraine Treatment, at BrightNewMe Chronic migraine affects around 2% of the population, and for those unfortunate enough to suffer from this debilitating condition it can have a major impact on quality of life. Chronic migraine is defined as experiencing general headaches on 15 or more days per month, and migrainous headaches on at least eight of these days. Botox® was licensed for treating chronic migraine in 2010, in cases where preventative medications have not been effective, or have not been tolerated by the patient. Treatment with Botox® has been shown to significantly reduce the number of headache days, and hence [...]